These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4395389)

  • 21. Mechanism of anti-inflammatory activity of -adrenoceptor blocking agents.
    Bhalla TN; Sinha JN; Tangri KK; Bhargava KP
    Eur J Pharmacol; 1972 Dec; 20(3):366-8. PubMed ID: 4404943
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological studies with tiprenolol and propranolol in man.
    Kesteloot H; Sluyts R; Floor-Wieringa A; van Strik R
    Eur J Pharmacol; 1973 Mar; 21(3):257-63. PubMed ID: 4145318
    [No Abstract]   [Full Text] [Related]  

  • 23. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of oxprenolol (Trasicor, Ciba 39089-Ba) on patterns of urinary sodium excretion in man.
    Singh BN; Till MR; Kelly DT
    Am J Cardiol; 1971 Apr; 27(4):372-5. PubMed ID: 4396725
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamic studies on the beta receptor blockader Kö 592 under rest and under exertion].
    Deibert K; Steim H; Heinrich K; Siller K
    Med Klin; 1972 Jun; 67(24):845-9. PubMed ID: 4403610
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antihypertensive and hemodynamic effects of beta-receptor blockaders with various action spectra].
    Lohmöller G; Lydtin H; Frohlich ED
    Adv Clin Pharmacol; 1976; 11():94-8. PubMed ID: 25572
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G; Byon KY; Kaufmann R; Fleckenstein A
    Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of LB-46, a new beta adrenergic blocking agent, on pulse and blood pressure at rest and after exercise in healthy volunteers.
    Mehta AB; Cooverji ND; Agrawal AB; Shah AC; Patnekar PN; Vora DD
    J Assoc Physicians India; 1971 Nov; 19(11):765-70. PubMed ID: 4399862
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124].
    Fujita T; Miyazaki M
    Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of respiratory and cardiovascular effects of isoproterenol, propranolol, and practolol in asthmatic and normal subjects.
    Ryo UY; Townley RG; Townley RG
    J Lab Clin Med; 1971 Dec; 78(6):1012. PubMed ID: 4399823
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
    Khanna NK
    Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
    [No Abstract]   [Full Text] [Related]  

  • 34. [Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride].
    Rosak C; Bartelt KM; Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2181. PubMed ID: 4146791
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective beta adrenergic receptor blockade in the rat.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1972 Aug; 182(2):256-63. PubMed ID: 4403093
    [No Abstract]   [Full Text] [Related]  

  • 36. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
    [No Abstract]   [Full Text] [Related]  

  • 37. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
    Marmo E; Caputi AP; Saini RK
    Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
    Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G
    G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of five beta-adrenoceptor antagonists on the effect of isoprenaline and acetylcholine on human isolated smooth muscle.
    Hedges A; Turner P
    Br J Pharmacol; 1971 Feb; 41(2):426P-427P. PubMed ID: 4396707
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.